Speculative Rally Weighed on LeMaitre Vascular (LMAT)
finance.yahoo.com · 2026-09-01
Riverwater Partners, an investment management company, released its ‘Small Cap Strategy’ Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchmark experienced one of its strongest risk-on rallies in recent memory, although the strategy remained ahead year-to-date. The quarter was defined […]
TickrTrends take: LeMaitre Vascular operates in the Healthcare sector and is currently assessed as undervalued by TickrTrends valuation metrics. A speculative rally in the stock creates a timing consideration for valuation-focused investors, as such rallies can temporarily inflate prices above intrinsic value levels. Observers of the company should monitor whether the stock's valuation remains attractive after speculative activity subsides or whether price appreciation has narrowed the gap to fair value.
Read the full story at finance.yahoo.com →
Is LMAT undervalued? See TickrTrends' fair value analysis →